Clinical Outcomes Following Urgent vs. Elective Percutaneous Mitral Valve Repair.
Cardiovasc Revasc Med
; 26: 6-11, 2021 05.
Article
em En
| MEDLINE
| ID: mdl-33199248
ABSTRACT
AIM:
To examine procedural and clinical outcomes among patients undergoing percutaneous mitral valve repair (PMVR) within an admission for acute-decompensated heart failure (ADHF). METHODS ANDRESULTS:
Prospective registry of all consecutive patients with symptomatic mitral regurgitation (MR) grade 3+ or 4+ who underwent PMVR our centre and classified in 2 groups elective group and urgent PMVR group (within the index admission for ADHF). Echocardiographic, procedural and clinical outcomes were compared between groups. 85 patients (median age 77.0 [67.8-83.4] years, 64.7% male) were treated within the recruitment period. Among them, 17 (20%) underwent urgent MitraClip®. Urgent PMVR were at a higher risk for conventional surgery (pâ¯=â¯0.002) and had worse estimated prognosis according to HF risk scores (pâ¯<â¯0.001). Overall technical success was 100%, without differences between groups. At 30â¯days, no differences were found in mortality, MR reduction and in NYHA functional improvement between groups. Cumulative estimated survival free from all-cause death was 92.9% (82.4% vs. 95.6%), 89.4% (82.4% vs. 91.1%), 76.3% (82.4 vs. 74.9%) at 6â¯months, 1-year and 2-years, respectively, with no significant differences between urgent or elective PMVR (pâ¯=â¯0.769).CONCLUSION:
MitraClip® implantation can be considered as an urgent therapy during admission for ADHF.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Implante de Prótese de Valva Cardíaca
/
Insuficiência da Valva Mitral
Tipo de estudo:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Cardiovasc Revasc Med
Assunto da revista:
ANGIOLOGIA
/
CARDIOLOGIA
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Espanha